Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 4 subfamily A member 2 pseudogene (OR4A2P) is classified as a pseudogene in the human genome[2]. While olfactory receptors are typically G protein-coupled receptors involved in the perception of smells by binding odorant molecules and triggering neuronal responses[1][2], pseudogenes like OR4A2P are generally non-functional due to accumulated sequence mutations, such as frame-shifts or premature stop codons, and do not produce active receptor protein[2][3]. These pseudogenes are prevalent in olfactory receptor families, reflecting evolutionary processes and low selection pressure for maintaining redundant receptors[3]. As a pseudogene, OR4A2P is not considered a therapeutic target, does not have established biological functions or disease roles, and lacks known drug interactions or utility as a biomarker. There is no safety concern or mechanism of drug action related to this entity. Its classification as a pseudogene makes it non-functional and not relevant for therapeutic modulation or direct disease association[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 4 subfamily A member 2 pseudogene (OR4A2P).